GNAZ

GNAZ encodes Gαz, an inhibitory G protein α subunit that transduces receptor signals into restraint of cellular growth, secretion, and barrier dynamics across neural, retinal, and endocrine tissues (PMID:25535338, PMID:37095509, PMID:40894772). In the nervous system, Gαz localizes to axonal growth cones, where it inhibits BDNF-stimulated cortical axon elongation (PMID:24321455) and acts downstream of Shh/Smo to mediate axon-repulsive guidance of enteric neurons (PMID:25535338). At the inner blood-retinal barrier, Gαz physically sequesters ADAM17 under basal conditions, blocking ADAM17-mediated degradation of claudin-5 and thereby preserving paracellular barrier integrity; this protective interaction is disrupted by blue light, and loss of Gαz produces ADAM17 hyperactivation, claudin-5 loss, and increased permeability (PMID:37095509). In pancreatic δ cells, Gαz couples FFAR4 activation to suppression of somatostatin secretion by reducing Ca2+ transients (PMID:40894772). Gαz expression itself is dynamically controlled: it undergoes circadian-regulated subcellular redistribution in photoreceptors downstream of CLOCK and dopamine D4 receptor signaling (PMID:29088301), is transcriptionally induced via a CDKN2B-AS1/E2F1 promoter axis (PMID:38077646), and is post-transcriptionally repressed by miR-20a-3p (PMID:41306771). In hepatocellular carcinoma and a neurofibroma context, Gαz activity feeds into ERK/MAPK signaling to promote proliferation, vasculogenic mimicry, and metastasis (PMID:34913528, PMID:38077646, PMID:41306771).

1. 1988 Medium

   Establishing the genomic locus of GNAZ provided the foundation for studying it as a discrete gene rather than an undefined G protein activity.

   Evidence Somatic cell hybrid panel hybridization with cDNA clones mapping to human chromosome 22

   PMID:2902634

   Open questions at the time

   • No functional role assigned
   • No tissue expression or protein activity characterized
2. 1995 Medium

   Tissue expression profiling localized GNAZ to neural structures of the fetal cochlea, first linking the gene to neural and ion-homeostasis contexts.

   Evidence Northern blot, in-situ hybridization, and immunohistochemistry in human fetal cochlea

   PMID:8975005

   Open questions at the time

   • Functional role inferred from localization, not tested
   • No signaling partner or receptor identified
3. 2013 High

   Genetic loss-of-function established an endogenous neuronal role for Gαz, showing it restrains neurotrophin-driven axon growth at the growth cone.

   Evidence Gz knockout mouse cortical neuron culture with axon growth measurement and localization imaging

   PMID:24321455

   Open questions at the time

   • Receptor coupling Gαz to BDNF signaling not defined
   • Downstream effectors of growth inhibition not identified
4. 2014 High

   Convergent genetic and pharmacologic approaches placed Gαz in the Shh/Smo axon-guidance pathway, defining it as a transducer of a repulsive guidance cue in the enteric nervous system.

   Evidence Enteric neuron axon turning assay, shRNA knockdown, dominant-negative inhibition, Gnaz KO mouse intestinal phenotyping

   PMID:25535338

   Open questions at the time

   • Direct biochemical link between Smo and Gαz not shown
   • Effector mechanism of repulsion downstream of Gαz unknown
5. 2017 High

   Genetic epistasis revealed that Gαz subcellular distribution is under circadian and dopaminergic control, connecting the protein to rhythmic photoreceptor physiology.

   Evidence Photoreceptor RNA analysis, constant-darkness experiments, and Clock-KO / D4 receptor-KO mouse retinas with localization assays

   PMID:29088301

   Open questions at the time

   • Functional consequence of Gαz redistribution in photoreceptors not defined
   • Signaling output downstream of redistributed Gαz unknown
6. 2021 Medium

   A tumor-derived variant assay first implicated GNAZ in MAPK pathway control, showing mutant Gαz elevates ERK1/2 activation.

   Evidence Whole-exome sequencing of a plexiform neurofibroma and cell-based ERK1/2 phosphorylation assay comparing mutant vs. wild-type GNAZ

   PMID:34913528

   Open questions at the time

   • Single case variant, not validated across tumors
   • Mechanism linking Gαz to ERK not resolved
7. 2023 High

   Co-IP and loss-of-function defined a non-canonical role for Gαz as a physical sequester of ADAM17 that protects claudin-5 and blood-retinal barrier integrity, and identified blue light as the disrupting stimulus.

   Evidence GNAZ-ADAM17 co-immunoprecipitation, siRNA knockdown in endothelial cells, ADAM17 inhibition, in vivo knockdown, ERG and permeability assays

   PMID:37095509

   Open questions at the time

   • Structural basis of the GNAZ-ADAM17 interaction not resolved
   • How blue light mechanistically disrupts the interaction unknown
8. 2023 Medium

   Promoter-level dissection established that GNAZ transcription is driven by a CDKN2B-AS1/E2F1 axis that supports HCC proliferation.

   Evidence RIP, ChIP of E2F1 at the GNAZ promoter, luciferase reporter, siRNA knockdown, and proliferation assays in HCC cells

   PMID:38077646

   Open questions at the time

   • Single lab; not independently replicated
   • Whether elevated GNAZ alone is sufficient for proliferation not isolated
9. 2025 High

   Genetic KO and species comparison defined Gαz as the obligate transducer coupling FFAR4 to suppression of somatostatin secretion in mouse δ cells via Ca2+ reduction, distinguishing it from a Gαz-independent insulin pathway.

   Evidence Gnaz knockout mouse islets, δ-cell ablation, SST-deficient mice, purified cell preparations, Ca2+ imaging, secretion assays, human EndoC-βH5 cells

   PMID:40894772

   Open questions at the time

   • Preprint, not peer-reviewed
   • Human δ-cell role of GNAZ not directly tested
10. 2025 Medium

    An upstream regulatory cascade was mapped showing miR-20a-3p directly represses GNAZ, and de-repression activates ERK signaling to drive vasculogenic mimicry and metastasis in HCC.

    Evidence Dual-luciferase reporter of miR-20a-3p targeting GNAZ 3'UTR, miRNA overexpression, tube formation and in vivo VM/metastasis models, ERK phosphorylation western blot

    PMID:41306771

    Open questions at the time

    • Single lab; not independently replicated
    • Direct biochemical step from Gαz to ERK phosphorylation not isolated

• The receptors and downstream effectors that link Gαz to its diverse tissue-specific outputs remain incompletely mapped, and the structural basis of its protein-protein sequestration functions is undefined.
• No unified effector pathway defined across neural, retinal, and endocrine contexts
• No structural model of Gαz-effector or Gαz-ADAM17 complexes
• GPCR partners coupling to Gαz in each tissue not systematically identified